JPRN-UMIN000006276已完成未知
The clinical study of the activated self-lymphocytes introduction therapy using a self-tumor (tissue) and a dendritic cells for a relapse and a advanced cancer. - The clinical study of the activated self-lymphocytes introduction therapy using a self-tumor (tissue) and a dendritic cells for a relapse and a advanced cancer.
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) The patients with autoimmune disease 2) The patients with complications having poor control. (An infection, diabetes, hypertension, ischemic heart disease, cerebral infraction, etc.). 3) The patients egnancy nursing mother and the pregnant likelihood(possibility). 4) The patients history of the drug allergy. 5) Other, the patients is judged inadequate by research contact person.
研究者
相似试验
已完成
不适用
Activation of the innate immune system in patients with primary hyperaldosteronismbloedvataandoeningen, arterioscleroseConn's syndromeprimary hyperaldosteronism10057166NL-OMON43020Radboud Universitair Medisch Centrum30
尚未招募
不适用
Correlation of specific type of white blood cells ratio during hospital admission in severity and outcome of acute stroke patientsCTRI/2021/08/035608Fortis Escorts Heart Institute
尚未招募
不适用
Safety and effectiveness of autologous leukocyte-rich platelet-rich plasma therapy (L-PRP therapy) for damage, deficit and prolonged healing in the musculoskeletal system of the human bodyintractable muscle of damaged tendon attachment and muscle tendon transitiontendonitis, humeral superior condylitis, elbow medial collateral ligament injury, knee medial collateral ligament injuryJPRN-UMIN000032134Jikei University Orthopedic5
已完成
不适用
Characterization of the immune response in patients with urothelial cell carcinoma of the bladder and during the BCG immunotherapy of bladder cancerC67Malignant neoplasm of bladderDRKS00003700Chirurgische Universitätsklinik, Abteilung für Urologie410
进行中（未招募）
不适用
Klinische Studie zur Überprüfung der Immunogenität unterschiedlicher Varianten einer FSME-Schnellimmunisierung mit inaktiviertem Frühsommer-Meningoenzephalitis-Impfstoff - FSME-Schnellimmunisierungs-StudieEUCTR2006-006955-10-ATniv.-Prof. Dr. Helmut Mittermayer108